pharma QA – Page 110

Hold Time Bioburden Rise during scale-up: water system and sanitation checks

Investigating the Rise of Hold Time Bioburden during Scale-up: Essential Checks for Water Systems and Sanitation In the realm of pharmaceutical manufacturing, the rise of bioburden during hold times poses…

Crystallization In Syrup in syrup production: packaging and transport risk assessment

Assessing Risks of Crystallization in Syrup Production: An Investigation Framework In the pharmaceutical manufacturing of liquid oral dosage forms, particularly syrups, the occurrence of crystallization poses significant challenges. These challenges…

Homogeneity Failure during method transfer: manufacturing vs lab root cause decision tree

Decision Tree for Investigating Homogeneity Failure during Method Transfer in Pharmaceutical Manufacturing In pharmaceutical manufacturing, ensuring drug formulation homogeneity is vital for both safety and efficacy, especially during method transfer.…

Viscosity Drift during method transfer: manufacturing vs lab root cause decision tree

Understanding Viscosity Drift during Method Transfer: A Decision Tree for Root Cause Analysis Viscosity drift during the method transfer process can lead to significant challenges in pharmaceutical manufacturing, potentially resulting…

Assay Oos during method transfer: investigation flowchart aligned to GMP

Investigating Assay OOS During Method Transfer: A Structured Flowchart for Compliance The occurrence of Out-of-Specification (OOS) results during assay method transfer represents a critical challenge for pharmaceutical manufacturers. This scenario…

Ph Drift during filling line setup: packaging and transport risk assessment

Assessing pH Drift During Filling Line Setup: A Comprehensive Investigation Approach The pharmaceutical manufacturing sector is no stranger to the challenges of maintaining product quality during the filling process, particularly…

Density Mismatch during bulk hold: packaging and transport risk assessment

Addressing Density Mismatch Risks During Bulk Hold in Pharmaceutical Manufacturing Density mismatch incidents during bulk hold can pose significant risks in pharmaceutical manufacturing, particularly in the packaging and transport stages…

Microbial Limits Failure after temperature excursion: investigation flowchart aligned to GMP

Investigative Workflow for Microbial Limits Failure Post Temperature Excursion In the pharmaceutical manufacturing environment, temperature excursions can pose significant risks, particularly concerning microbial limits. When microbial limits fail following a…

Tag: pharma QA

Hold Time Bioburden Rise during scale-up: water system and sanitation checks

Crystallization In Syrup in syrup production: packaging and transport risk assessment

Homogeneity Failure during method transfer: manufacturing vs lab root cause decision tree

Viscosity Drift during method transfer: manufacturing vs lab root cause decision tree

Assay Oos during method transfer: investigation flowchart aligned to GMP

Ph Drift during filling line setup: packaging and transport risk assessment

Density Mismatch during bulk hold: packaging and transport risk assessment

Microbial Limits Failure after temperature excursion: investigation flowchart aligned to GMP

Foaming And Air Entrapment during filling line setup: manufacturing vs lab root cause decision tree

Microbial Limits Failure during filling line setup: mixing, sampling, and hold-time controls

Fill Volume Variability during filling line setup: investigation flowchart aligned to GMP

Ph Drift during bulk hold: water system and sanitation checks